BRIEF published on 01/29/2026 at 07:35, 7 months 23 days ago Q.beyond annonce des résultats financiers améliorés pour 2025 Expansion Internationale Augmentation De L'EBITDA Stratégie 2028 Résultats Financiers 2025 Q.au-delà AG
PRESS RELEASE published on 01/29/2026 at 07:30, 7 months 23 days ago q.beyond increases EBITDA to € 12.3 million in 2025 and generates positive consolidated net income q.beyond AG increases EBITDA to €12.3 million and achieves positive consolidated net income in 2025. Further plans for share buybacks, dividends, and marketing of AI expertise EBITDA Q.beyond AG Share Buybacks Consolidated Net Income AI Expertise
BRIEF published on 01/09/2026 at 09:05, 8 months 12 days ago Progrès constants pour q.beyond AG malgré un contexte de marché difficile Rentabilité Acquisitions Stratégiques Services Cloud Q.au-delà AG Perspectives Pour L'exercice 2026
BRIEF published on 01/09/2026 at 09:05, 8 months 12 days ago Steady Progress for q.beyond AG amid Challenging Market Conditions Cloud Services Profitability Q.beyond AG Strategic Acquisitions FY26 Outlook
PRESS RELEASE published on 01/09/2026 at 09:00, 8 months 12 days ago Original-Research: q.beyond AG (von NuWays AG): BUY Research update: q.beyond AG (DE0005137004) classified by NuWays AG. FY25 demonstrates resilient business model with positive EBITDA. FY26 outlook includes sales growth and margin expansion NuWays AG Q.beyond AG Research Update FY25 FY26
BRIEF published on 12/12/2025 at 12:22, 9 months 9 days ago Q.beyond Initiates Capital Reduction to Enable Future Buybacks and Dividends Q.beyond AG Dividends Share Buybacks Capital Reduction 2028 Strategy
BRIEF published on 12/12/2025 at 12:22, 9 months 9 days ago Q.beyond initie une réduction de capital pour permettre de futurs rachats d'actions et le versement de dividendes. Réduction De Capital Dividendes Rachats D'actions Stratégie 2028 Q.au-delà AG
BRIEF published on 12/12/2025 at 12:20, 9 months 9 days ago Q.beyond AG to Implement Capital Reduction Reverse Stock Split Dividend Distribution Share Buybacks Capital Reduction Shareholder Meeting
BRIEF published on 12/12/2025 at 12:20, 9 months 9 days ago Q. au-delà de AG pour mettre en œuvre une réduction de capital Regroupement D'actions Inversé Rachats D'actions Distribution De Dividendes Assemblée Générale Des Actionnaires Réduction Du Capital
PRESS RELEASE published on 12/12/2025 at 12:17, 9 months 9 days ago q.beyond plans to execute capital reduction as prerequisite for future share buybacks and dividends q.beyond AG plans capital reduction for future share buybacks and dividends, setting stage for shareholders' participation and stabilizing share price Q.beyond AG Dividends Share Buybacks Financial Strategy Capital Reduction
Published on 09/21/2026 at 15:45, 2 hours 21 minutes ago Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 3 hours 46 minutes ago Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 4 hours 1 minute ago Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 4 hours 6 minutes ago Dateline Files Motion to Resume Operations at Colosseum
Published on 09/21/2026 at 13:45, 4 hours 21 minutes ago Nine Mile Metals DDH WD-26-11 Intersects 2 High Grade VMS Zones Over 27.6M Including 3.08% CU-EQ Over 10.70M, 3.27% CU-EQ Over 9.30M and 4.30% CU-EQ Over 5.0M
Published on 09/21/2026 at 17:45, 21 minutes ago EQS-Adhoc: Airbus reports share buyback transactions 11-18 September 2026
Published on 09/21/2026 at 17:45, 21 minutes ago Charwood Energy poursuit sur un rythme de croissance élevé. Chiffre d’affaires semestriel en hausse de +43 % à 5,6 M€.
Published on 09/21/2026 at 17:45, 21 minutes ago Charwood Energy continues to grow at a strong pace. H1 revenue up +43% to €5.6m.
Published on 09/21/2026 at 17:00, 1 hour 6 minutes ago Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Published on 09/21/2026 at 18:01, 5 minutes ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 20 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 20 minutes ago WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026
